Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and between 25 and 64 years old
- People who have been diagnosed with cervical cancer (CIN3 or above, at any stage) or who need a procedure called a conization (a procedure to remove tissue from the cervix, for any reason)
- People who have not yet started any form of cancer treatment before joining the study
- People who are able to give written consent to participate
- People who are able to understand the study information brochure and what the study involves
Who may not be able to join:
- People who have had a hysterectomy (surgical removal of the uterus)
- People who are pregnant or are within 6 weeks of giving birth
- People who have received treatment for cervical cancer or pre-cancer within the 6 months before joining the study
- People who are currently participating in another clinical trial that is testing a medical device, drug, or vaccine at the same time
- People who are unable to give informed consent
- People who have severe anaemia (very low red blood cell levels)
- People who have received a blood transfusion within two weeks before the blood sample is collected for the study
- People for whom giving a blood sample would pose a risk to their overall health
- People who have tested positive for HIV, Hepatitis B, or Hepatitis C
- People who have issues with alcohol or drug misuse
- People who have any current or past condition or abnormality that, in the opinion of the trial doctor, could affect the study results or make participation not in the person's best interest (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wiebren Tjalma, MD, PhD, Universiteit Antwerpen
Phone: 032659130
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of (epi)genetic biomarkers for cervical cancer and precancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.